Lung Neoplasms: all 7,333 studies
Page 67 of 74. Open to participants first (1,554), then studies with results posted, then the rest; newest registration first within each.
- QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLCWithdrawnNCT00385398Phase 2
- Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid TumorsCompletedNCT00385177Phase 1
- The Utility of FDG-PET for Radiation Treatment in NSCLCStatus unknownNCT00385164
- The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung CancerWithdrawnNCT00380666Not applicable
- Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLCTerminatedNCT00378404Phase 1
- Zinc Supplements in Lowering Cadmium Levels in SmokersCompletedNCT00376987Phase 2
- Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior TherapyCompletedNCT00375193Phase 2
- Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)TerminatedNCT00373204Phase 2
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
- AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy RegimenCompletedNCT00372788Phase 2
- High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR MutationsCompletedNCT00372515Phase 1
- Endobronchial Ultrasound vs Mediastinoscopy in NSCLCCompletedNCT00372203Phase 2
- Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung CancerTerminatedNCT00372073Phase 2
- A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)CompletedNCT00370383Phase 2
- Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
- A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung CancerTerminatedNCT00369447Phase 1/2
- Web-based Intervention for Lung Cancer Patients and Their Informal CaregiversCompletedNCT00365963Phase 3
- Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung CancerTerminatedNCT00365183Phase 2
- Study of XL647 in Subjects With Non-Small-Cell Lung CancerCompletedNCT00364780Phase 2
- The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung CancerStatus unknownNCT00364663
- Adrenal Function in Patients With Newly Diagnosed Lung CancerCompletedNCT00364624
- Transitoriness in Cancer Patients, Psychosocial Issues in Cancer CareCompletedNCT00364078
- Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung CancerCompletedNCT00363428Not applicable
- Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)TerminatedNCT00359450Phase 2
- A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung CancerCompletedNCT00359359Phase 1/2
- Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLCTerminatedNCT00356941Phase 1
- A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung CancerTerminatedNCT00354562Phase 1/2
- Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLCCompletedNCT00354549Phase 2
- Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung CancerWithdrawnNCT00352950Phase 1
- Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00352391
- Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung TumoursCompletedNCT00351962Not applicable
- A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung CancerCompletedNCT00349492Phase 3
- TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerCompletedNCT00349219Phase 3
- Trial on Refinement of Early Stage Lung Cancer Adjuvant TherapyCompletedNCT00349089Phase 2
- Study of NOV-002 in Combination With Chemotherapy to Treat Lung CancerCompletedNCT00347412Phase 3
- CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00346801Phase 1
- Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00346320Not applicable
- The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung CancerTerminatedNCT00345059Phase 3
- Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior TherapyCompletedNCT00343720Phase 2
- AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerCompletedNCT00343408Phase 1
- A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related RashTerminatedNCT00343187Phase 2
- A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal MinersCompletedNCT00342264
- Genetic Epidemiology of Lung CancerCompletedNCT00341835
- Prevention of Tumor Spread Due to Lung Cancer SurgeryCompletedNCT00341380
- Impact of Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk and Receptivity to Quit SmokingCompletedNCT00341341
- Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung CancerCompletedNCT00340847
- Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, ChinaCompletedNCT00340405
- Genetic Epidemiology of Lung Cancer and SmokingCompletedNCT00340340
- DNA Repair, p53 and Apoptosis Phenotypes in Lung CancerCompletedNCT00339859
- First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR GeneStatus unknownNCT00339586Phase 2
- "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung CancerCompletedNCT00338481Phase 4
- Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer SurvivorsCompletedNCT00335491Not applicable
- Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00334763Phase 2
- Phase II Iressa + Irradiation Followed by Chemo in NSCLCCompletedNCT00333294Phase 2
- CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung CancerCompletedNCT00330746Phase 2
- Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung CancerCompletedNCT00330044Phase 1
- LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With ChemotherapyCompletedNCT00328588Phase 2
- Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsCompletedNCT00327288Phase 1
- A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerCompletedNCT00325494Phase 1
- AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaStatus unknownNCT00324597Phase 1
- Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung CancerCompletedNCT00322751Phase 1
- Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLCCompletedNCT00321334Phase 3
- Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerTerminatedNCT00321308Phase 2
- Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung CancerCompletedNCT00320359Phase 3
- Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.CompletedNCT00319969Phase 2
- Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLCStatus unknownNCT00319800Phase 2
- Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLCCompletedNCT00319514Phase 2
- A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung CancerCompletedNCT00317200Phase 2
- Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung CancerTerminatedNCT00316433Phase 2
- Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung CancerTerminatedNCT00315211Phase 2
- Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung CancerCompletedNCT00315185Phase 2
- Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung CancerWithdrawnNCT00313690Phase 1/2
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung CancerCompletedNCT00312819Phase 2/3
- Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)TerminatedNCT00310232Phase 3
- Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung CancerCompletedNCT00310219Not applicable
- Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
- Computer-Assisted Counseling in Helping African American Smokers Stop SmokingCompletedNCT00310141Not applicable
- Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyCompletedNCT00310115
- Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00309998Phase 2
- Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00309972Phase 3
- Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCompletedNCT00308529Phase 2
- Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00305786Phase 2
- Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung CancerCompletedNCT00305617Not applicable
- Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerCompletedNCT00303914
- Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving ChemotherapyStatus unknownNCT00300729Phase 3
- IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00300586Phase 3
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung CancerTerminatedNCT00299390Phase 2
- A Study of IRESSA in Relapsed and Refractory Small Cell Lung CancerCompletedNCT00298688Phase 2
- DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung CancerTerminatedNCT00298298Phase 1/2
- A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung CancerCompletedNCT00297089Phase 1/2
- Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.CompletedNCT00295672Phase 2
- Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00294931Phase 2
- A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy RegimensCompletedNCT00294736Phase 1
- Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung CancerCompletedNCT00294190Phase 2
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00293280Phase 2
- An Open, Randomized, Multicentre, Phase II Pilot StudyCompletedNCT00293085Phase 2
- Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLCTerminatedNCT00291850Phase 2
- Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + EtoposideCompletedNCT00290953Phase 2/3